![Slanix Alex](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Slanix Alex
Directeur/Membre du Conseil chez
PROMIS NEUROSCIENCES, INC.
Fortune : - $ au 31/05/2026
Profil
Slanix Paul T.
Alex is currently Director at ProMIS Neurosciences, Inc. since 2025 and Portfolio Manager & President at Ally Bridge Group (NY) LLC since 2024.
Former roles include Equity Research Analyst at Credit Suisse Securities (USA) LLC (Broker), Assistant Vice President at RBC Capital Markets LLC from 2017 to 2018, Associate Consultant at Bionest Partners LLC, Analyst at Consonance Capital Management LP from 2018 to 2020, and Senior Biotech Analyst at Tri Locum Partners LP from 2020 to 2022.
Education includes a doctorate from St. John's University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Slanix Alex
| Sociétés | Poste | Début |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Directeur/Membre du Conseil | 22/10/2025 |
Ally Bridge Group (NY) LLC
 Ally Bridge Group (NY) LLC Investment ManagersFinance Provides investment advice | President | 01/01/2024 |
Anciens postes connus de Slanix Alex
| Sociétés | Poste | Fin |
|---|---|---|
Tri Locum Partners LP
 Tri Locum Partners LP Investment ManagersFinance Tri Locum’ Funds seeks to generate risk-adjusted returns in all market and economic conditions by employing a long/short strategy that aims to capitalize on innovation in the healthcare sector, across biotechnology, pharmaceuticals, services, and medical devices. The Funds invest primarily in equity and equity-related securities of companies within the healthcare sector in the Americas, Asia and Europe. The firm employs an investment process based on fundamental, bottom-up research to seek to identify investments that will generate attractive returns while seeking to minimize risk. They intend to overlay their investment process with a proprietary portfolio construction and risk management process that results in limited market and factor correlation. | Analyst-Equity | 01/07/2022 |
Consonance Capital Management LP
 Consonance Capital Management LP Investment ManagersFinance Consonance Capital aims to deliver exceptional, uncorrelated risk-adjusted returns through investment opportunities in the publicly traded stocks of healthcare companies. The firm seeks to meet this strategy by investing in publicly traded micro-cap, small-cap and mid-cap healthcare equities. They believe the public healthcare market lends itself to an active long/short strategy. Consonance Capital is focused on creating long and short portfolios driven by the opportunity for absolute return and alpha creation. The firm seeks to identify and analyze companies trading below their intrinsic value, which may include deep value as well as growth companies. | Analyst-Equity | 01/06/2020 |
RBC Capital Markets LLC
 RBC Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/07/2018 |
Credit Suisse Securities (USA) LLC (Broker)
 Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/05/2017 |
Bionest Partners LLC
 Bionest Partners LLC Electronic Equipment/InstrumentsElectronic Technology Manufactures and markets Biomarker testing machines | Corporate Officer/Principal | - |
Formation de Slanix Alex
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Credit Suisse Securities (USA) LLC (Broker)
Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
ProMIS Neurosciences, Inc.
 ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
St. John's University
 St. John's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RBC Capital Markets LLC
RBC Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Bionest Partners LLC
Bionest Partners LLC Electronic Equipment/InstrumentsElectronic Technology Manufactures and markets Biomarker testing machines | Electronic Technology |
Consonance Capital Management LP
Consonance Capital Management LP Investment ManagersFinance Consonance Capital aims to deliver exceptional, uncorrelated risk-adjusted returns through investment opportunities in the publicly traded stocks of healthcare companies. The firm seeks to meet this strategy by investing in publicly traded micro-cap, small-cap and mid-cap healthcare equities. They believe the public healthcare market lends itself to an active long/short strategy. Consonance Capital is focused on creating long and short portfolios driven by the opportunity for absolute return and alpha creation. The firm seeks to identify and analyze companies trading below their intrinsic value, which may include deep value as well as growth companies. | Finance |
Ally Bridge Group (NY) LLC
Ally Bridge Group (NY) LLC Investment ManagersFinance Provides investment advice | Finance |
Tri Locum Partners LP
Tri Locum Partners LP Investment ManagersFinance Tri Locum’ Funds seeks to generate risk-adjusted returns in all market and economic conditions by employing a long/short strategy that aims to capitalize on innovation in the healthcare sector, across biotechnology, pharmaceuticals, services, and medical devices. The Funds invest primarily in equity and equity-related securities of companies within the healthcare sector in the Americas, Asia and Europe. The firm employs an investment process based on fundamental, bottom-up research to seek to identify investments that will generate attractive returns while seeking to minimize risk. They intend to overlay their investment process with a proprietary portfolio construction and risk management process that results in limited market and factor correlation. | Finance |
